P20226 (TBP_HUMAN) Homo sapiens (Human)

TATA-box-binding protein UniProtKBInterProSTRINGInteractive Modelling

339 aa; Sequence (Fasta) ; (Isoform 2)

Available Structures

42 Experimental Structures

DescriptionOligo-stateLigandsStructureRange
Human core-PIC in the open state Heteromer
O15514; P13984; P19387; P19388; P23193; P24928; P29083; P29084; P30876; P35269; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403;
MG; 11×ZN;153-337
Assess
Human holo-PIC in the initial transcribing state (no IIS) Heteromer
O15514; P13984; P18074; P19387; P19388; P19447; P24928; P29083; P29084; P30876; P35269; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
MG; 10×ZN;153-337
Assess
Human core-PIC in the initial transcribing state Heteromer
O15514; P13984; P19387; P19388; P23193; P24928; P29083; P29084; P30876; P35269; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403;
MG; 11×ZN;153-337
Assess
Human core-PIC in the closed state Heteromer
O15514; P13984; P19387; P19388; P23193; P24928; P29083; P29084; P30876; P35269; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403;
MG; 11×ZN;153-337
Assess
Human holo-PIC in the closed state Heteromer
O15514; P13984; P18074; P19387; P19388; P19447; P23193; P24928; P29083; P29084; P30876; P32780; P35269; P36954; P50613; P51946; P51948; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
MG; 17×ZN;SF4;153-337
Assess
Human core-PIC in the initial transcribing state (no IIS) Heteromer
O15514; P13984; P19387; P19388; P24928; P29083; P29084; P30876; P35269; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403;
MG; 11×ZN;153-337
Assess
Human holo-PIC in the closed state Heteromer
O15514; P13984; P18074; P19387; P19388; P19447; P23193; P24928; P29083; P29084; P30876; P35269; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
MG; 11×ZN;153-337
Assess
Human holo-PIC in the open state Heteromer
O15514; P13984; P18074; P19387; P19388; P19447; P23193; P24928; P29083; P29084; P30876; P35269; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
MG; 11×ZN;153-337
Assess
Human holo-PIC in the initial transcribing state Heteromer
O15514; P13984; P18074; P19387; P19388; P19447; P23193; P24928; P29083; P29084; P30876; P35269; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
MG; 11×ZN;153-337
Assess
Structure of the human Mediator-bound transcription pre-initiation complex Heteromer
A0JLT2; O15514; O43513; O60244; O75448; O75586; P13984; P18074; P19387; P19388; P19447; P24928; P29083; P29084; P30876; P32780; P35269; P36954; P50613; P51946; P51948; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13503; Q13888; Q13889; Q15528; Q6P2C8; Q6ZYL4; Q71SY5; Q92759; Q96G25; Q96HR3; Q96RN5; Q9BTT4; Q9BUE0; Q9H204; Q9H944; Q9NPJ6; Q9NVC6; Q9NWA0; Q9NX70; Q9P086; Q9ULK4; Q9Y2X0; Q9Y3C7;
MG; 16×ZN;SF4;153-337
Assess
HUMAN TFIIA/TBP/DNA COMPLEX Heteromer
P52655; P52657;
159-338
Assess
Crystal Structure of the NC2-TBP-DNA Ternary Complex Heteromer
Q01658; Q14919;
159-338
Assess
CRYSTAL STRUCTURE OF A HUMAN TBP CORE DOMAIN-HUMAN TFIIB CORE DOMAIN COMPLEX BOUND TO AN EXTENDED, … Heteromer
Q00403;
158-337
Assess
Human TFIID canonical state Heteromer
O00268; P21675; P49848; Q12962; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8;
159-338
Assess
Human TFIID Lobe A canonical Heteromer
O00268; P21675; P49848; Q12962; Q15542; Q15543; Q15544; Q16514; Q16594; Q5VWG9;
159-338
Assess
Human TFIID bound to promoter DNA and TFIIA Heteromer
O00268; P21675; P49848; P52655; P52657; Q12962; Q15542; Q15545; Q16514; Q16594; Q6P1X5; Q7Z7C8;
159-338
Assess
Structure of human TFIID-IIA bound to core promoter DNA Heteromer
P21675; P49848; P52655; P52657; Q15545; Q6P1X5; Q7Z7C8;
159-338
Assess
RNA polymerase II pre-initiation complex with open promoter DNA Heteromer
A0A287ADR4; A0A4X1UK25; A0A4X1ULF2; A0A4X1VYD0; F1SKN8; I3LCH3; I3LGP4; I3LJZ9; I3LN51; I3LSI7; P13984; P18074; P19447; P29083; P29084; P32780; P35269; P51948; P52655; P52657; P60899; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
SF4; 15×ZN;ADP;MG;BEF;159-337
Assess
RNA polymerase II core pre-initiation complex with open promoter DNA Heteromer
A0A287ADR4; A0A4X1UK25; A0A4X1ULF2; A0A4X1VYD0; F1SKN8; I3LCH3; I3LGP4; I3LJZ9; I3LN51; I3LSI7; P13984; P29083; P29084; P35269; P52655; P52657; P60899; Q00403;
10×ZN;MG;159-337
Assess
RNA polymerase II pre-initiation complex with closed promoter DNA in proximal position Heteromer
A0A287ADR4; A0A4X1UK25; A0A4X1ULF2; A0A4X1VYD0; F1SKN8; I3LCH3; I3LGP4; I3LJZ9; I3LN51; I3LSI7; P13984; P18074; P19447; P29083; P29084; P32780; P35269; P51948; P52655; P52657; P60899; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
SF4; 17×ZN;MG;159-337
Assess
RNA polymerase II pre-initiation complex with closed promoter DNA in distal position Heteromer
A0A287ADR4; A0A4X1UK25; A0A4X1ULF2; A0A4X1VYD0; F1SKN8; I3LCH3; I3LGP4; I3LJZ9; I3LN51; I3LSI7; P13984; P18074; P19447; P29083; P29084; P32780; P35269; P51948; P52655; P52657; P60899; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
SF4; 17×ZN;MG;159-337
Assess
RNA polymerase II core pre-initiation complex with closed promoter DNA in proximal position Heteromer
A0A287ADR4; A0A4X1UK25; A0A4X1ULF2; A0A4X1VYD0; F1SKN8; I3LCH3; I3LGP4; I3LJZ9; I3LN51; I3LSI7; P13984; P29083; P29084; P35269; P52655; P52657; P60899; Q00403;
10×ZN;MG;159-337
Assess
Human Mediator with RNA Polymerase II Pre-initiation complex Heteromer
A0A287ADR4; A0A4X1UK25; A0A4X1ULF2; A0A4X1VYD0; A0JLT2; F1SKN8; I3LCH3; I3LGP4; I3LJZ9; I3LN51; I3LSI7; O43513; O60244; O75586; P13984; P18074; P19447; P29083; P29084; P32780; P35269; P50613; P51946; P51948; P52655; P52657; P60899; Q00403; Q13503; Q13888; Q13889; Q15528; Q6P2C8; Q6ZYL4; Q92759; Q96G25; Q96HR3; Q9BTT4; Q9BUE0; Q9H204; Q9H944; Q9NPJ6; Q9NVC6; Q9NWA0; Q9P086; Q9Y3C7;
SF4; 18×ZN;MG;159-337
Assess
RNA polymerase II core pre-initiation complex with closed promoter DNA in distal position Heteromer
A0A287ADR4; A0A4X1UK25; A0A4X1ULF2; A0A4X1VYD0; F1SKN8; I3LCH3; I3LGP4; I3LJZ9; I3LN51; I3LSI7; P13984; P29083; P29084; P35269; P52655; P52657; P60899; Q00403;
10×ZN;MG;159-337
Assess
TFIID-based holo PIC on SCP promoter Heteromer
A0A481BYI6; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1UK25; A0A4X1ULF2; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; I3LCH3; O00268; P13984; P18074; P19447; P21675; P24928; P29083; P29084; P32780; P35269; P49848; P50613; P51946; P51948; P52655; P52657; P60899; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759;
16×ZN;SF4;MG;161-337
Assess
TFIID-based intermediate PIC on SCP promoter Heteromer
A0A481BYI6; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1UK25; A0A4X1ULF2; A0A4X1VEK9; A0A4X1VKG7; I3LCH3; I3LSI7; O00268; P13984; P21675; P29083; P29084; P35269; P49848; P52655; P52657; P60899; Q00403; Q12962; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8;
10×ZN;MG;161-337
Assess
p53-bound TFIID-based core PIC on HDM2 promoter Heteromer
A0A481BYI6; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1UK25; A0A4X1ULF2; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; I3LCH3; O00268; P13984; P21675; P35269; P49848; P52655; P52657; P60899; Q00403; Q12962; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8;
ZN;MG;161-337
Assess
TFIID-based intermediate PIC on PUMA promoter Heteromer
A0A480TA59; A0A481BYI6; A0A481DF93; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1UK25; A0A4X1ULF2; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; O00268; P13984; P21675; P29083; P29084; P35269; P49848; P52655; P52657; P60899; Q00403; Q12962; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8;
10×ZN;MG;161-337
Assess
TFIID lobe A subcomplex Heteromer
O00268; P49848; Q12962; Q15542; Q15543; Q15544; Q16514; Q16594; Q5VWG9;
161-337
Assess
TFIID-based core PIC on SCP promoter Heteromer
A0A481BYI6; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1UK25; A0A4X1ULF2; A0A4X1VEK9; A0A4X1VKG7; I3LCH3; I3LSI7; O00268; P13984; P21675; P35269; P49848; P52655; P52657; P60899; Q00403; Q12962; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8;
ZN;MG;161-337
Assess
TFIID-based core PIC on PUMA promoter Heteromer
A0A481BYI6; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1UK25; A0A4X1ULF2; A0A4X1VEK9; A0A4X1VKG7; I3LCH3; I3LSI7; O00268; P13984; P21675; P35269; P49848; P52655; P52657; P60899; Q00403; Q12962; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8;
ZN;MG;161-337
Assess
SCP promoter-bound TFIID-TFIIA in post TBP-loading state Heteromer
O00268; P21675; P49848; P52655; P52657; Q12962; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8;
161-337
Assess
SCP promoter-bound TFIID-TFIIA in initial TBP-loading state Heteromer
O00268; P21675; P49848; P52655; P52657; Q12962; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8;
161-337
Assess
TFIID in canonical conformation Heteromer
O00268; P21675; P49848; Q12962; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8;
161-337
Assess
p53-bound TFIID-based holo PIC on HDM2 promoter Heteromer
A0A481BYI6; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1UK25; A0A4X1ULF2; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; I3LCH3; O00268; P13984; P18074; P19447; P21675; P24928; P29083; P29084; P32780; P35269; P49848; P50613; P51946; P51948; P52655; P52657; P60899; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759;
16×ZN;SF4;MG;161-337
Assess
TFIID in rearranged conformation Heteromer
O00268; P21675; P49848; P52655; P52657; Q12962; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8;
161-337
Assess
Human TFIIB-related factor 2 (Brf2) and TBP bound to U6#2 promoter Heteromer
Q9HAW0;
MG;159-334
Assess
Human TFIIB-related factor 2 (Brf2) and TBP bound to RPPH1 promoter Heteromer
Q9HAW0;
MG;159-334
Assess
Human TFIIB-related factor 2 (Brf2) and TBP bound to TRNAU1 promoter Heteromer
Q9HAW0;
159-334
Assess
TFIIIB -TBP/Brf2/DNA and SANT domain of Bdp1- Heteromer
A6H8Y1; Q9HAW0;
159-334
Assess
TATA BINDING PROTEIN (TBP)/DNA COMPLEXmonomer159-338
Assess
HUMAN TBP CORE DOMAIN COMPLEXED WITH DNAmonomer159-337
Assess

1 Homology model built on isoform sequence

IsoformOligo-stateLigandsQMEANDisCoTemplateRangeSeq id (%)
Isoform 2monomer0.855fur.1.A139-318
100.00
Assess

Alignments